Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
15.44
+0.20 (1.31%)
May 23, 2025, 2:45 PM CST
-3.14%
Market Cap 8.34B
Revenue (ttm) 3.14B
Net Income (ttm) -197.17M
Shares Out 542.18M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE 184.69
Dividend 0.49 (3.15%)
Ex-Dividend Date May 29, 2024
Volume 12,480,000
Average Volume 10,977,107
Open 15.04
Previous Close 15.24
Day's Range 15.04 - 15.83
52-Week Range 10.91 - 21.98
Beta 0.67
RSI 52.09
Earnings Date Aug 19, 2025

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. The company operates in China and internationally. The company was formerly known as Porton Fine Ch... [Read more]

Sector Healthcare
Founded 2005
Employees 4,214
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.